Loading...

HPV ASSOCIATED SQUAMOUS CELL CARCINOMA PROFILE (HPV DNA DETECTION + P16INK4A)

image not found

NABL Cap Accredited 

The HPV Associated Squamous Cell Carcinoma Profile combines HPV DNA detection with the p16INK4a biomarker to assess the presence and oncogenic activity of high-risk HPV types. This profile helps evaluate the risk of HPV-driven squamous cell carcinomas, especially in the cervix, head, neck, and anogenital regions. Metropolis Healthcare uses advanced molecular and immunohistochemical methods to deliver accurate and clinically meaningful results. It supports early diagnosis, prognosis assessment, and treatment planning in suspected HPV-related malignancies. 

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 6,890.00

Sample Type: Slides ,Tissue

Fasting Not Required


Notes:H0324

Frequently Asked Questions (FAQ's):

What does the HPV Associated Squamous Cell Carcinoma Profile include?
It includes high-risk HPV DNA detection along with p16INK4a expression analysis, a key marker of HPV-related oncogenic transformation.

Why is HPV testing combined with p16INK4a?
The combination improves diagnostic accuracy by confirming both the presence of high-risk HPV and its biological activity in causing cellular changes.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses sensitive PCR-based assays for HPV DNA and advanced immunohistochemistry for p16INK4a evaluation.

Who should undergo this test?
Individuals with suspected HPV-related squamous cell lesions or abnormal biopsy findings may be advised to take this test.

What sample is required for the test?
Biopsy tissue or cytology samples are typically used, depending on clinical context.

How do the results help clinicians?
The results help distinguish HPV-driven carcinomas from non-HPV tumors, guiding prognosis and personalized treatment decisions.

Is this test useful for follow-up?
Yes, it can assist in monitoring recurrence risk and evaluating treatment response in HPV-associated cancers.

Why choose Metropolis Healthcare for this test?

Metropolis Healthcare provides high-quality molecular diagnostics and expert pathology interpretation for reliable and actionable outcomes 

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab